EcoDrugPlus

Retinoic Acid Receptor Rxr-Beta-A-Like

Ensembl ID : ENSNBRG00000017426
Gene Symbol: LOC102775931
3 Cross references
211 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSNBRG00000017566
Gene Symbol: RARB
4 Cross references
393 Possible Orthologues:

Retinoic Acid Receptor Beta-Like

Ensembl ID : ENSNBRG00000015832
Gene Symbol: LOC102800168
2 Cross references
380 Possible Orthologues:

Retinoic Acid Receptor Gamma

Ensembl ID : ENSNBRG00000018123
Gene Symbol: RARG
2 Cross references
353 Possible Orthologues:

Retinoic Acid Receptor Gamma-A-Like

Ensembl ID : ENSNBRG00000019309
Gene Symbol: LOC102796146
3 Cross references
377 Possible Orthologues:

Rho-Associated Protein Kinase 1-Like

Ensembl ID : ENSNBRG00000006322
Gene Symbol: LOC102778415
3 Cross references
213 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSNBRG00000010802
Gene Symbol: LOC102782942
3 Cross references
225 Possible Orthologues:

Rho-Associated Protein Kinase 2-Like

Ensembl ID : ENSNBRG00000020410
Gene Symbol: LOC102780311
3 Cross references
225 Possible Orthologues:

Ribosomal Protein L11

Ensembl ID : ENSNBRG00000009835
Gene Symbol: RPL11
1 Cross references
81 Possible Orthologues:

Ribosomal Protein L22

Ensembl ID : ENSNBRG00000011493
Gene Symbol: RPL22
3 Cross references
199 Possible Orthologues:

Ribosomal Protein L27a

Ensembl ID : ENSNBRG00000015457
Gene Symbol: RPL27A
2 Cross references
514 Possible Orthologues:

Ribosomal Protein L29

Ensembl ID : ENSNBRG00000022109
Gene Symbol: RPL29
1 Cross references
496 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).